Published in Future Cardiol on January 01, 2013
Prevalence of dyslipidemia in Iranian children and adolescents: A systematic review. J Res Med Sci (2015) 0.77
A Pilot Randomized Controlled Clinical Trial to Assess Tolerance and Efficacy of Navy Bean and Rice Bran Supplementation for Lowering Cholesterol in Children. Glob Pediatr Health (2017) 0.75
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
The spread of obesity in a large social network over 32 years. N Engl J Med (2007) 34.75
The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics (2004) 31.85
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Sick individuals and sick populations. Int J Epidemiol (1985) 23.44
Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95
Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med (1998) 15.09
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet (2010) 14.24
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med (2010) 8.70
Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA (2005) 8.07
Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics (2011) 7.30
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94
Lipid screening and cardiovascular health in childhood. Pediatrics (2008) 6.62
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Type 2 diabetes in children and adolescents. American Diabetes Association. Diabetes Care (2000) 6.21
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial. Lancet (2011) 5.08
Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med (1986) 4.26
Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet (2011) 4.12
Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis. BMJ (2007) 3.64
Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis (1999) 3.33
Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation (1974) 3.29
Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults. Heart (2007) 3.29
Associations of weight-based teasing and emotional well-being among adolescents. Arch Pediatr Adolesc Med (2003) 2.81
Prevalence of cardiovascular disease risk factors among US adolescents, 1999-2008. Pediatrics (2012) 2.75
Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA (2007) 2.66
16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer (2011) 2.32
Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol (2011) 2.20
Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation (2011) 2.08
Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study. PLoS Med (2012) 2.07
Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA (2012) 2.04
Overly aggressive new guidelines for lipid screening in children: evidence of a broken process. Pediatrics (2012) 1.95
Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess (2000) 1.80
Effectiveness and cost-effectiveness of blood pressure screening in adolescents in the United States. J Pediatr (2010) 1.76
Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study. BMJ (2012) 1.69
Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb (1993) 1.61
Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents. Arch Pediatr Adolesc Med (2009) 1.54
A summary of results of the Dietary Intervention Study in Children (DISC): lessons learned. Prog Cardiovasc Nurs (2003) 1.48
Coronary heart disease mortality trends in the Netherlands 1972-2007. Heart (2011) 1.42
A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2007) 1.22
Risk-taking behaviors of adolescents with extreme obesity: normative or not? Pediatrics (2011) 1.21
Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics (2008) 1.16
Greater dietary intake of simple carbohydrate is associated with lower concentrations of high-density-lipoprotein cholesterol in hypercholesterolemic children. Am J Clin Nutr (1998) 1.12
Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis (2011) 1.10
A three-country study on the components of the metabolic syndrome in youths: the BIG Study. Int J Pediatr Obes (2010) 1.07
Perceived risk and representations of cardiovascular disease and preventive behaviour in people diagnosed with familial hypercholesterolemia: a cross-sectional questionnaire study. J Health Psychol (2010) 1.03
Is universal pediatric lipid screening justified? JAMA (2012) 1.00
Insight into the causes of the recent secular trend in pediatric obesity: Common sense does not always prevail for complex, multi-factorial phenotypes. Prev Med (2006) 0.99
The relationship of air pollution and surrogate markers of endothelial dysfunction in a population-based sample of children. BMC Public Health (2011) 0.95
Metabolic syndrome in childhood and increased arterial stiffness in adulthood: the Cardiovascular Risk In Young Finns Study. Ann Med (2011) 0.92
Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability. Paediatr Drugs (2011) 0.91
The American Heart Association and the Million Hearts Initiative: a presidential advisory from the American Heart Association. Circulation (2011) 0.86
Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects. Pediatr Cardiol (2009) 0.84
Are parents' self-reported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guidelines. Pediatrics (1993) 0.81
Statin use in children in the United States. Pediatrics (2008) 0.80
Child-parent screening for familial hypercholesterolemia. J Pediatr (2011) 0.79
Prevalence of metabolic syndrome and associated risk factors among Korean adolescents: analysis from the Korean national survey. Asia Pac J Public Health (2011) 0.78
Normal growth in high-risk hyperlipidemic children and adolescents with dietary intervention. Prev Med (1999) 0.76
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Nontraditional risk factors and biomarkers for cardiovascular disease: mechanistic, research, and clinical considerations for youth: a scientific statement from the American Heart Association. Circulation (2011) 1.81
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol (2011) 1.58
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Diabetes Care (2014) 1.47
Endothelial pulse amplitude testing: feasibility and reproducibility in adolescents. J Pediatr (2009) 1.34
Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation (2014) 1.32
Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol (2011) 1.22
The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association. Circulation (2015) 1.13
Obesity is a common comorbidity in children with congenital and acquired heart disease. Pediatrics (2007) 1.11
Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation (2014) 0.96
Dynamic evolution of practice guidelines: analysis of deviations from assessment and management plans. Pediatrics (2012) 0.95
Promotion of physical activity for children and adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation (2013) 0.92
Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol (2011) 0.91
Temporal trends in pulse pressure and mean arterial pressure during the rise of pediatric obesity in US children. J Am Heart Assoc (2014) 0.82
Cardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter. Curr Opin Pediatr (2010) 0.81
Cardiovascular Consequences of Childhood Secondhand Tobacco Smoke Exposure: Prevailing Evidence, Burden, and Racial and Socioeconomic Disparities: A Scientific Statement From the American Heart Association. Circulation (2016) 0.80
Stakeholders' Perspectives on Stakeholder-engaged Research (SER): Strategies to Operationalize Patient-centered Outcomes Research Principles for SER. Med Care (2017) 0.78
Childhood obesity: today and tomorrow's health challenge. J Obes (2013) 0.77
Declining cholesterol levels in US youths: a reason for optimism. JAMA (2012) 0.75
Leveraging electronic health records to notify pediatric patients of a drug recall. JAMA Pediatr (2013) 0.75
Adolescent Dyslipidemia and Standardized Lifestyle Modification: Benchmarking Real-World Practice. J Am Coll Cardiol (2016) 0.75
Hypertension in children and adolescents: more questions than answers. Arch Pediatr Adolesc Med (2012) 0.75
Pediatric metabolic syndrome: from prevention to treatment. Cholesterol (2012) 0.75